United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - amoxapine (unii: r63vq857ot) (amoxapine - unii:r63vq857ot) - amoxapine 25 mg - amoxapine is indicated for the relief of symptoms of depression in patients with neurotic or reactive depressive disorders as well as endogenous and psychotic depressions. it is indicated for depression accompanied by anxiety or agitation. amoxapine is contraindicated in patients who have shown prior hypersensitivity to dibenzoxazepine compounds. it should not be given concomitantly with monoamine oxidase inhibitors. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressants and monoamine oxidase inhibitors simultaneously. when it is desired to replace a monoamine oxidase inhibitor with amoxapine, a minimum of 14 days should be allowed to elapse after the former is discontinued. amoxapine should then be initiated cautiously with gradual increase in dosage until optimum response is achieved. the drug is not recommended for use during the acute recovery phase following myocardial infarction.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - amoxapine (unii: r63vq857ot) (amoxapine - unii:r63vq857ot) - amoxapine 50 mg - amoxapine is indicated for the relief of symptoms of depression in patients with neurotic or reactive depressive disorders as well as endogenous and psychotic depressions. it is indicated for depression accompanied by anxiety or agitation. amoxapine is contraindicated in patients who have shown prior hypersensitivity to dibenzoxazepine compounds. it should not be given concomitantly with monoamine oxidase inhibitors. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressants and monoamine oxidase inhibitors simultaneously. when it is desired to replace a monoamine oxidase inhibitor with amoxapine, a minimum of 14 days should be allowed to elapse after the former is discontinued. amoxapine should then be initiated cautiously with gradual increase in dosage until optimum response is achieved. the drug is not recommended for use during the acute recovery phase following myocardial infarction.

United States - English - NLM (National Library of Medicine)

chartwell rx, llc - amoxapine (unii: r63vq857ot) (amoxapine - unii:r63vq857ot) - amoxapine is indicated for the relief of symptoms of depression in patients with neurotic or reactive depressive disorders as well as endogenous and psychotic depressions. it is indicated for depression accompanied by anxiety or agitation. amoxapine is contraindicated in patients who have shown prior hypersensitivity to dibenzoxazepine compounds. it should not be given concomitantly with monoamine oxidase inhibitors. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressants and monoamine oxidase inhibitors simultaneously. when it is desired to replace a monoamine oxidase inhibitor with amoxapine, a minimum of 14 days should be allowed to elapse after the former is discontinued. amoxapine should then be initiated cautiously with gradual increase in dosage until optimum response is achieved. the drug is not recommended for use during the acute recovery phase following myocardial infarction.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - amoxapine - oral tablet - 100mg

Canada - English - Health Canada

lederle cyanamid canada inc. - amoxapine - tablet - 25mg - amoxapine 25mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

lederle cyanamid canada inc. - amoxapine - tablet - 50mg - amoxapine 50mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

lederle cyanamid canada inc. - amoxapine - tablet - 100mg - amoxapine 100mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

wyeth-ayerst canada inc. - amoxapine - tablet - 25mg - amoxapine 25mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

wyeth-ayerst canada inc. - amoxapine - tablet - 50mg - amoxapine 50mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

wyeth-ayerst canada inc. - amoxapine - tablet - 100mg - amoxapine 100mg - tricyclics and other norepinephrine-reuptake inhibitors